ICP
LH icon

Ironvine Capital Partners’s Labcorp LH Stock Holding History

Ironvine Capital Partners’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.3M Sell
54,819
-10,730
-16% -$2.82M 1.43% 24
2026
Q1 		$17.5M Hold
65,549
– – 1.92% 20
2025
Q4 		$16.4M Sell
65,549
-18,746
-22% -$4.98M 1.65% 22
2025
Q3 		$24.2M Sell
84,295
-6,475
-7% -$1.73M 2.41% 18
2025
Q2 		$23.8M Buy
90,770
+111
+0.1% +$27K 2.47% 16
2025
Q1 		$21.1M Sell
90,659
-1,713
-2% -$416K 2.29% 19
2024
Q4 		$21.2M Sell
92,372
-38
-0% -$8.72K 2.27% 18
2024
Q3 		$20.7M Buy
92,410
+141
+0.2% +$31K 2.22% 18
2024
Q2 		$18.8M Sell
92,269
-56
-0.1% -$11.4K 2.06% 20
2024
Q1 		$20.2M Buy
92,325
+36
+0% +$7.93K 2.21% 20
2023
Q4 		$21M Buy
92,289
+107
+0.1% +$22.5K 2.52% 21
2023
Q3 		$18.5M Sell
92,182
-14,751
-14% -$3.11M 2.38% 21
2023
Q2 		$22.2M Buy
106,933
+171
+0.2% +$33.2K 2.69% 20
2023
Q1 		$21M Buy
106,762
+33
+0% +$6.79K 2.65% 21
2022
Q4 		$21.6M Buy
106,729
+1,236
+1% +$242K 2.8% 17
2022
Q3 		$18.6M Buy
105,493
+789
+0.8% +$162K 2.49% 22
2022
Q2 		$21.1M Buy
104,704
+943
+0.9% +$201K 2.59% 19
2022
Q1 		$23.5M Buy
103,761
+551
+0.5% +$130K 2.53% 20
2021
Q4 		$27.9M Sell
103,210
-3,739
-3% -$926K 2.86% 14
2021
Q3 		$25.9M Buy
106,949
+231
+0.2% +$58.2K 2.75% 15
2021
Q2 		$25.3M Sell
106,718
-3,761
-3% -$857K 2.77% 15
2021
Q1 		$24.2M Sell
110,479
-1,663
-1% -$334K 2.82% 16
2020
Q4 		$19.6M Sell
112,142
-15,966
-12% -$2.76M 2.45% 18
2020
Q3 		$20.7M Sell
128,108
-1,443
-1% -$229K 2.6% 17
2020
Q2 		$18.5M Buy
129,551
+62
+0% +$8.58K 2.45% 18
2020
Q1 		$14.1M Buy
129,489
+34,687
+37% +$5M 2.2% 21
2019
Q4 		$13.8M Buy
94,802
+2,061
+2% +$298K 1.66% 24
2019
Q3 		$13.4M Buy
92,741
+9,283
+11% +$1.35M 1.96% 24
2019
Q2 		$12.8M Buy
83,458
+2,729
+3% +$381K 2.09% 24
2019
Q1 		$10.6M Buy
+80,729
New +$9.94M 2% 23

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ironvine Capital Partners's LH Position: Q2 2026 in Review

Ironvine Capital Partners reduced its Labcorp (LH) stake by 16% in Q2 2026, selling an estimated $2.82M and leaving 54,819 shares worth $15.3M. The position accounts for 1.43% of the portfolio, ranked #24.

Ironvine Capital Partners first reported a position in LH in Q1 2019 and has held it in 30 quarters since. The position peaked at $27.9M in Q4 2021. 1,059 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Ironvine Capital Partners held 54,819 shares of Labcorp worth $15.3M as of Q2 2026.
  • Ironvine Capital Partners sold 10,730 Labcorp shares in Q2 2026, an estimated $2.82M.
  • Labcorp made up 1.43% of Ironvine Capital Partners's portfolio in Q2 2026, its #24 holding.
  • Ironvine Capital Partners first reported a position in Labcorp in Q1 2019 and has held it in 30 quarters since.
  • Ironvine Capital Partners's Labcorp position peaked at $27.9M in Q4 2021.
  • 1,059 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Ironvine Capital Partners's 13F filing for Q2 2026, filed 10 Aug 2026.